Cargando…

Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes

β(2)‐Adrenoceptor (β(2)‐AR) signaling decreases the transcriptional activity of forkhead box O (FoxO), but the underlying mechanisms remain incompletely understood. Here, we investigated how β(2)‐AR signaling regulates the protein abundance of FoxO and its transcriptional activity in skeletal muscle...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimamoto, Saki, Nakashima, Kazuki, Nishikoba, Nao, Kohrogi, Rukana, Ohtsuka, Akira, Fujimura, Shinobu, Ijiri, Daichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886325/
https://www.ncbi.nlm.nih.gov/pubmed/35038382
http://dx.doi.org/10.1002/2211-5463.13368
_version_ 1784660644788699136
author Shimamoto, Saki
Nakashima, Kazuki
Nishikoba, Nao
Kohrogi, Rukana
Ohtsuka, Akira
Fujimura, Shinobu
Ijiri, Daichi
author_facet Shimamoto, Saki
Nakashima, Kazuki
Nishikoba, Nao
Kohrogi, Rukana
Ohtsuka, Akira
Fujimura, Shinobu
Ijiri, Daichi
author_sort Shimamoto, Saki
collection PubMed
description β(2)‐Adrenoceptor (β(2)‐AR) signaling decreases the transcriptional activity of forkhead box O (FoxO), but the underlying mechanisms remain incompletely understood. Here, we investigated how β(2)‐AR signaling regulates the protein abundance of FoxO and its transcriptional activity in skeletal muscle. We observed that stimulation of β(2)‐AR with its selective agonist, clenbuterol, rapidly decreased FoxO1 mRNA expression, and this was accompanied by a decrease in either FoxO1 protein level or FoxO transcriptional activity. We subsequently observed that miR‐374b‐5p and miR‐7a‐1‐3p were rapidly upregulated in response to β(2)‐AR stimulation. Transfection with mimics of either miRNA successfully decreased FoxO1 mRNA. Moreover, because β(2)‐AR stimulation increased cAMP concentration, pretreatment with an adenylyl cyclase inhibitor canceled out these effects of β(2)‐AR stimulation. These results suggest that β(2)‐AR stimulation results in rapid upregulation of miR‐374b‐5p and miR‐7a‐1‐3p in myotubes, which in turn results in a decrease in FoxO1 mRNA expression via the β(2)‐AR–cAMP signaling pathway.
format Online
Article
Text
id pubmed-8886325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88863252022-03-04 Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes Shimamoto, Saki Nakashima, Kazuki Nishikoba, Nao Kohrogi, Rukana Ohtsuka, Akira Fujimura, Shinobu Ijiri, Daichi FEBS Open Bio Research Articles β(2)‐Adrenoceptor (β(2)‐AR) signaling decreases the transcriptional activity of forkhead box O (FoxO), but the underlying mechanisms remain incompletely understood. Here, we investigated how β(2)‐AR signaling regulates the protein abundance of FoxO and its transcriptional activity in skeletal muscle. We observed that stimulation of β(2)‐AR with its selective agonist, clenbuterol, rapidly decreased FoxO1 mRNA expression, and this was accompanied by a decrease in either FoxO1 protein level or FoxO transcriptional activity. We subsequently observed that miR‐374b‐5p and miR‐7a‐1‐3p were rapidly upregulated in response to β(2)‐AR stimulation. Transfection with mimics of either miRNA successfully decreased FoxO1 mRNA. Moreover, because β(2)‐AR stimulation increased cAMP concentration, pretreatment with an adenylyl cyclase inhibitor canceled out these effects of β(2)‐AR stimulation. These results suggest that β(2)‐AR stimulation results in rapid upregulation of miR‐374b‐5p and miR‐7a‐1‐3p in myotubes, which in turn results in a decrease in FoxO1 mRNA expression via the β(2)‐AR–cAMP signaling pathway. John Wiley and Sons Inc. 2022-02-07 /pmc/articles/PMC8886325/ /pubmed/35038382 http://dx.doi.org/10.1002/2211-5463.13368 Text en © 2022 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Shimamoto, Saki
Nakashima, Kazuki
Nishikoba, Nao
Kohrogi, Rukana
Ohtsuka, Akira
Fujimura, Shinobu
Ijiri, Daichi
Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes
title Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes
title_full Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes
title_fullStr Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes
title_full_unstemmed Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes
title_short Suppression of FoxO1 mRNA by β(2)‐adrenoceptor–cAMP signaling through miR‐374b‐5p and miR‐7a‐1‐3p in C2C12 myotubes
title_sort suppression of foxo1 mrna by β(2)‐adrenoceptor–camp signaling through mir‐374b‐5p and mir‐7a‐1‐3p in c2c12 myotubes
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886325/
https://www.ncbi.nlm.nih.gov/pubmed/35038382
http://dx.doi.org/10.1002/2211-5463.13368
work_keys_str_mv AT shimamotosaki suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes
AT nakashimakazuki suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes
AT nishikobanao suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes
AT kohrogirukana suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes
AT ohtsukaakira suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes
AT fujimurashinobu suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes
AT ijiridaichi suppressionoffoxo1mrnabyb2adrenoceptorcampsignalingthroughmir374b5pandmir7a13pinc2c12myotubes